logo
Share SHARE
FONT-SIZE Plus   Neg

Shire To Buy FerroKin BioSciences For $100 Mln Plus Milestone Payments

Shire plc (SHP.L,SHPGY: Quote) Thursday reported agreeing to acquire privately-held FerroKin Biosciences Inc. for a cash consideration of $100 million and milestone payments of up to $225 million. The purchase is expected to add the iron chelator FBS0701, which is seen as a possible treatment for transfusional iron overload to Shire's hematology portfolio.

While phase 2 trials of FBS0701 are currently underway, Shire sees additional trials as well as a global filing for indications of Myelodysplastic Syndrome and hemoglobinopathies, with a launch target of 2016. Further, such key FerroKin employees as Founder and CEO Hugh Rienhoff may provide consulting services during a transition period.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Warner Bros. Interactive Entertainment said its upcoming mobile game releases in 2015 would include Batman, DC Comics, LEGO, "Game of Thrones," and "Mortal Combat X". A study claims the ghastly civil war in Syria is the result of a severe drought brought about by global warming - in what is yet the strongest link between climate change and armed conflict. U.S. electronics giant Apple Inc. (AAPL) regained the top spot in the world smartphone market from South Korea's Samsung Electronics Co Ltd. after a gap of three years, according to a report released Tuesday by market research firm Gartner, Inc. (IT). Apple sold 74.832 million smartphones in the...
comments powered by Disqus
Follow RTT